Fed Holds Rates Steady, Cuts Growth Outlook, Raises Inflation Forecast

FABPulous

company

About

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.

  • 1 - 10

Details

Last Funding Type
Series A
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.

FABPulous is a company based in The Netherlands. It was spun out of Maastricht University at the end of 2008. In December 2009 FABPulous closed a first equity financing round co-led by Thuja Capital, Health Innovations, Limburg Ventures and NV Industriebank LIOF.

The company has developed a technology that allows a simple, robust and ultra-rapid diluted plasma preparation from a drop of blood. This offers great advantages in the point-of-care (POC) and home testing setting, over current technology. It concerns a disposable plasma preparation device that can be integrated with many IVD detection platforms, such lateral flow devices. The first product application under development by FABPulous is a rapid test for the cardiac biomarker heart-type fatty acid binding protein (H-FABP), to aid in the first-line diagnosis of acute myocardial infarction.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€1.80M
FABPulous has raised a total of €1.80M in funding over 2 rounds. Their latest funding was raised on Feb 4, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 4, 2015 Series B €1.80M 1 Detail
Jan 11, 2010 Series A 1 Limburg Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
FABPulous is funded by 1 investors. Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Limburg Ventures Series B